DOI QR코드

DOI QR Code

Review of Current Facial Allotransplantation and Future Aspects

안면동종이식의 현황고찰과 전망

  • Seo, Mi Hyun (Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University) ;
  • Lee, Jung A (Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University) ;
  • Oh, Jin Sil (Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University) ;
  • Kim, Soung Min (Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University) ;
  • Myoung, Hoon (Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University) ;
  • Lee, Jong Ho (Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University)
  • 서미현 (서울대학교 치의학대학원 구강악안면외과학교실, 치학연구소) ;
  • 이정아 (서울대학교 치의학대학원 구강악안면외과학교실, 치학연구소) ;
  • 오진실 (서울대학교 치의학대학원 구강악안면외과학교실, 치학연구소) ;
  • 김성민 (서울대학교 치의학대학원 구강악안면외과학교실, 치학연구소) ;
  • 명훈 (서울대학교 치의학대학원 구강악안면외과학교실, 치학연구소) ;
  • 이종호 (서울대학교 치의학대학원 구강악안면외과학교실, 치학연구소)
  • Received : 2013.02.28
  • Accepted : 2013.09.21
  • Published : 2013.09.30

Abstract

Advances in immunosuppressive treatments and microsurgical techniques have rendered composite tissues allotransplantation (CTA), such as heteregeneous or non-organ tissues, possible in humans. CTA has evolved dramatically since the first successful rat hind limb allotransplantation. Numerous clinical applications including face, hand, trachea, larynx, and vascularized joint have been performed. Although composite tissue allografts are still in their infancy, they have opened a new era in the field of transplantation surgery and pathology, so that maxillofacial reconstructive surgeons may occasionally be faced with the challenge of diagnosing skin refection of a composite tissue allograft. Facial allotransplantation (FAT) is a new surgical technique that could be considered as a new paradigm in facial reconstruction. Since the first human FAT had been achieved in 2005, 17 cases have been reported in the world up to date. However, many problems such as life-long immunosuppression, immune rejection, ethical problems and psychological problems are remained, so facial CTA is new reconstructive option with no general acceptance. The authors reviewed the indications, the results of 17 cases and their complications, and additional consideration factors in this article, and intended to raise the awareness of oral and maxillofacial surgeons in this type of facial transplantation.

Keywords

References

  1. Gordon CR, Nazzal J, Lozano-Calderan SA, et al. From experimental rat hindlimb to clinical face composite tissue allotransplantation: historical background and current status. Microsurgery 2006;26:566-72. https://doi.org/10.1002/micr.20296
  2. Losee JE, Fletcher DR, Gorantla VS. Human facial allotransplantation: patient selection and pertinent considerations. J Craniofac Surg 2012;23:260-4. https://doi.org/10.1097/SCS.0b013e318241b958
  3. Dubernard JM, Lengelé B, Morelon E, et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med 2007;357:2451-60. https://doi.org/10.1056/NEJMoa072828
  4. Siemionow M, Ozturk C. Face transplantation: outcomes, concerns, controversies, and future directions. J Craniofac Surg 2012;23:254-9. https://doi.org/10.1097/SCS.0b013e318241b920
  5. Siemionow MZ, Gordon CR. Institutional review board-based recommendations for medical institutions pursuing protocol approval for facial transplantation. Plast Reconstr Surg 2010;126:1232-9. https://doi.org/10.1097/PRS.0b013e3181ee482d
  6. Lantieri L. Face transplant: a paradigm change in facial reconstruction. J Craniofac Surg 2012;23:250-3. https://doi.org/10.1097/SCS.0b013e318241c10b
  7. Alam DS, Papay F, Djohan R, et al. The technical and anatomical aspects of the world's first near-total human face and maxilla transplant. Arch Facial Plast Surg 2009;11:369-77.
  8. Pomahac B, Pribaz J, Eriksson E, et al. Three patients with full facial transplantation. N Engl J Med 2012;366:715-22. https://doi.org/10.1056/NEJMoa1111432
  9. Siemionow M, Papay F, Alam D, et al. Near-total human face transplantation for a severely disfigured patient in the USA. Lancet 2009;374:203-9. https://doi.org/10.1016/S0140-6736(09)61155-7
  10. Lantieri L, Meningaud JP, Grimbert P, et al. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study. Lancet 2008;372:639-45. https://doi.org/10.1016/S0140-6736(08)61277-5
  11. Guo S, Han Y, Zhang X, et al. Human facial allotransplantation: a 2-year follow-up study. Lancet 2008;372:631-8. https://doi.org/10.1016/S0140-6736(08)61276-3
  12. Lantieri L, Hivelin M, Audard V, et al. Feasibility, reproducibility, risks and benefits of face transplantation: a prospective study of outcomes. Am J Transplant 2011;11:367-78. https://doi.org/10.1111/j.1600-6143.2010.03406.x
  13. Pomahac B, Lengele B, Ridgway EB, et al. Vascular considerations in composite midfacial allotransplantation. Plast Reconstr Surg 2010;125:517-22. https://doi.org/10.1097/PRS.0b013e3181c82e6f
  14. Devauchelle B, Badet L, Lengelé B, et al. First human face allograft: early report. Lancet 2006;368:203-9. https://doi.org/10.1016/S0140-6736(06)68935-6
  15. Cavadas P. Clinical update & update on hand and face transplant outcomes. In: Proceeding of the 2010 American Society for Reconstructive Transplantation 2nd Biennial Meeting. Chicago; American Society for Reconstructive Transplantation:2010.
  16. Gomez-Cia T, Sicilia-Castro D, Infante-Cossio P, et al. Second human facial allotransplantation to restore a severe defect following radical resection of bilateral massive plexiform neurofibromas. Plast Reconstr Surg 2011;127:995-6. https://doi.org/10.1097/PRS.0b013e318200b00b
  17. Bueno J, Barret JP, Serracanta J, et al. Logistics and strategy of multiorgan procurement involving total face allograft. Am J Transplant 2011;11:1091-7. https://doi.org/10.1111/j.1600-6143.2011.03489.x
  18. Petruzzo P, Testelin S, Kanitakis J, et al. First human face transplantation: 5 years outcomes. Transplantation 2012;93:236-40. https://doi.org/10.1097/TP.0b013e31823d4af6
  19. Leonard DA, Gordon CR, Sachs DH, Cetrulo CL Jr. Immunobiology of face transplantation. J Craniofac Surg 2012;23:268-71. https://doi.org/10.1097/SCS.0b013e318241b8e0
  20. Kanitakis J. The challenge of dermatopathological diagnosis of composite tissue allograft rejection: a review. J Cutan Pathol 2008;35:738-44. https://doi.org/10.1111/j.1600-0560.2007.00889.x
  21. Siemionow M, Klimczak A. Basics of immune responses in transplantation in preparation for application of composite tissue allografts in plastic and reconstructive surgery: part I. Plast Reconstr Surg 2008;121:4e-12e.
  22. Cendales LC, Kanitakis J, Schneeberger S, et al. The banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 2008;8:1396-400. https://doi.org/10.1111/j.1600-6143.2008.02243.x
  23. Huang WC, Lin JY, Wallace CG, Chuang WY, Wei FC, Liao SK. Vascularized bone grafts within composite tissue allotransplants can autocreate tolerance through mixed chimerism with partial myeloablative conditioning: an experimental study in rats. Plast Reconstr Surg 2010;125:1095-103.
  24. Pomahac B, Pribaz J. Facial composite tissue allograft. J Craniofac Surg 2012;23:265-7. https://doi.org/10.1097/SCS.0b013e318241b8b8